| Product Name | AP-2α/β |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TFAP2A antibody; AP2TF antibody; TFAP2 antibody; Transcription factor AP-2-alpha antibody; AP2-alpha antibody; AP-2 transcription factor antibody; Activating enhancer-binding protein 2-alpha antibody; Activator protein 2 antibody; AP-2 antibody; TFAP2B antibody; Transcription factor AP-2-beta antibody; AP2-beta antibody; Activating enhancer-bindi antibody; |
| Product description | The protein encoded by this gene is a transcription factor that binds the consensus sequence 5'-GCCNNNGGC-3'. The encoded protein functions as either a homodimer or as a heterodimer with similar family members. This protein activates the transcription of some genes while inhibiting the transcription of others. Defects in this gene are a cause of branchiooculofacial syndrome (BOFS). Three transcript variants encoding different isoforms have been found for this gene., |
| Immunogen | The antiserum was produced against synthesized peptide derived from human AP-2. AA range:388-437 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:500-1:2000 IHC:1:100-1:300 |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Alternative Names | TFAP2A antibody AP2TF antibody TFAP2 antibody Transcription factor AP-2-alpha antibody AP2-alpha antibody AP-2 transcription factor antibody Activating enhancer-binding protein 2-alpha antibody Activator protein 2 antibody AP-2 antibody TFAP2B antibody Transcription factor AP-2-beta antibody AP2-beta antibody Activating enhancer-bindi antibody |
|---|---|
| Molecular Weight(MW) | 49 kDa |
| Positive Control | Prostate,Teratocarcinoma, |
|---|---|
| Application Notes | WB:1:500-1:2000 IHC:1:100-1:300 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
